Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients-Reference-Cited by-同舟云学术

Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients

Published:2018-01-29 Issue:3 Volume:7 Page:831-841
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Byun Ja Min¹²^ORCID,Shin Dong-Yeop¹³^ORCID,Hong Junshik¹³,Kim Inho¹⁴,Kim Hyun Kyung⁵,Lee Dong Soon⁵,Koh Youngil¹³⁴,Yoon Sung-Soo¹³⁴

Affiliation:

1. Department of Internal Medicine; Seoul National University College of Medicine; Seoul National University Hospital; Seoul Korea

2. Department of Internal Medicine; Seoul Metropolitan Government Seoul National University Boramae Medical Center; Seoul Korea

3. Biomedical Research Institute; Seoul National University Hospital; Seoul Korea

4. Cancer Research Institute; Seoul National University Hospital; Seoul Korea

5. Department of Laboratory Medicine; Seoul National University College of Medicine; Seoul Korea

Funder

Korea Health Industry Development Institute

Ministry of Health & Welfare, Republic of Korea

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference30 articles.

1. Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party;Lee;Int. J. Hematol.,2010

2. Novel agents in the treatment of multiple myeloma: a review about the future;Naymagon;J. Hematol. Oncol.,2016

3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

4. Novel agents have a significant impact on survival of patients with multiple myeloma;Lamm;Wien. Klin. Wochenschr.,2015

5. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines;Kumar;Mayo Clin. Proc.,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805);International Journal of Hematology;2022-05-11

2. Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH;Blood Advances;2022-01-17

3. Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma;memo - Magazine of European Medical Oncology;2021-11-22

4. Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma;Cytometry Part B: Clinical Cytometry;2021-05-31

5. Bortezomib-based regimens improve the prognosis of newly diagnosed MM patients with chromosomal aberrations except for del(17q13);Medicine;2021-05-07